Daré Bioscience Announces Publication in Menopause for Phase 1/2 Clinical Trial of DARE-HRT1 for Treatment of Vasomotor Symptoms due to Menopause

Daré Bioscience has announced the publication of data from a Phase 1/2 clinical trial in Menopause: The Journal of The North American Menopause Society. The study evaluated the safety and pharmacokinetics of DARE-HRT1, an investigational intravaginal ring designed to release bio-identical estrogen and progestogen hormone therapy continuously over a 28-day period as part of a hormone therapy regi..